Deciduous Therapeutics
Home - Deciduous Therapeutics Inc.
United States · $5.8M raised
- Business Model
- B2B
- Website
- deciduoustx.com
- Total Funding
- $5.8M
- Last Round
- $5.8M Series BJan 2023
- Rounds
- 3
About
Biotech developing immune-modulatory therapies targeting senescent cells to extend healthy human lifespan.
Summary
Deciduous Therapeutics is a Biotech company based in United States. It has raised $5.8M in total across 3 rounds, most recently a $5.8M Series B round in Jan 2023. Investors include CRV (Charles River) and LongGame.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...